NCT05603442

Brief Summary

The investigators hypothesize an alternative way to perform thoracic paravertebral block, by placing the needle tip over and behind the transverse process of vertebra, via the thoracic intervertebral foramen. This anesthetic procedure is called thoracic intervertebral foramen block. The study aims to verify the spread of dye on to the the nervous structures of retropleural space (the ventral rami, the communicating rami, and the sympathetic trunk), and into the thoracic paravertebral space and epidural space. To accomplish this, a prospective cadaveric study was designed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 7, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 2, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2024

Completed
Last Updated

December 3, 2024

Status Verified

November 1, 2024

Enrollment Period

2.5 years

First QC Date

October 21, 2022

Last Update Submit

November 29, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Retropleural spread

    Assess mL of dye on to the nervous structures of retropleural space (the ventral rami, the communicating rami, and the sympathetic trunk)

    During autopsy

  • Thoracic paravertebral spread

    Assess mL of dye on to the thoracic paravertebral space

    During autopsy

  • Epidural spread

    Assess mL of dye on the epidural space

    During autopsy

Secondary Outcomes (3)

  • Iatrogenic damages

    During autopsy

  • Distance (mm) between the catheter tip and the thoracic intervertebral foramen content is also evaluated

    During autopsy

  • Second look ultrasound scan

    After the anesthetic procedure

Study Arms (1)

Thoracic intervertebral foramen block

EXPERIMENTAL

The thoracic intervertebral foramen block is performed at second (T2), fifth (T5), ninth (T9), and twelfth (T12) thoracic vertebra. The ultrasonography is performed by using a high-frequency linear-array ultrasound transducer. A Tuohy needle is inserted in-plane to the ultrasound beam in a lateral-to-medial direction gently to contact the spinous process, into the skeletal muscle plane of the erector spinae muscle. Then, the needle tip is moved to reach the angle between the transverse process and spinous process. Subsequently, the needle tip is gently inserted and advanced for 2 mm along with the superior limit of the vertebral pedicle, until losing contact with the bone. Five ml methylene blue 1% dye (MB) are subsequently injected. The anesthetic procedure is bilaterally performed. Two continuous catheter sets were used and threaded 1 cm from the needle tip, for a bilateral continuous block. The catheters are inserted from the caudal to the cephalic direction.

Procedure: Thoracic intervertebral foramen block

Interventions

The thoracic intervertebral foramen block is performed by placing the needle tip over and behind the transverse process of vertebra, via the thoracic intervertebral foramen.

Thoracic intervertebral foramen block

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • corps for which autopsy is required

You may not qualify if:

  • corps under Legal custody of Italian Low

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Salvatore Academic Hospital of L'Aquila

L’Aquila, L'Aquila, 67100, Italy

Location

Study Officials

  • Emiliano Petrucci, MD

    San Salvatore Acadeci Hospital of L'Aquila (Italy)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

October 21, 2022

First Posted

November 2, 2022

Study Start

June 7, 2022

Primary Completion

November 27, 2024

Study Completion

November 27, 2024

Last Updated

December 3, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations